DSpace at EWHA: Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine

Browse

My Repository

DSpace at EWHA의과대학 의학과 Journal papers

View : 553 Download: 3

Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine

Title: Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine

Authors: Lee C.K.; Kim H.-S.; Ye B.D.; Lee K.-M.; Kim Y.S.; Rhee S.Y.; Kim H.-J.; Yang S.-K.; Moon W.; Koo J.-S.; Lee S.-H.; Seo G.S.; Park S.J.; Choi C.H.; Jung S.-A.; Hong S.N.; Im J.P.; Kim E.S.

Ewha Authors: 정성애

SCOPUS Author ID: 정성애

Issue Date: 2014

Journal Title: Journal of Crohn's and Colitis

ISSN: 1876-4479

Citation: Journal of Crohn's and Colitis vol. 8, no. 5, pp. 384 - 391

Publisher: Elsevier

Indexed: SCOPUS

Document Type: Article

Abstract: Crohn's disease; Immunosuppressive agents; Inflammatory bowel disease; Pneumococcal vaccine

DOI: 10.1016/j.crohns.2013.09.022

Appears in Collections:: 의과대학 > 의학과 > Journal papers

Files in This Item:

Export: RIS (EndNote); XLS (Excel); XML

Show full item record

Find@EWHA

qrcode

: search

BROWSE